From the spinal cord to the aging brain, the landscape of neuroregenerative research is rapidly evolving with innovative, multi-targeted strategies. This week, we explore how scientists are combining cell-based and molecular therapies to tackle spinal cord injury from multiple angles, uncovering how aerobic exercise supports brain health by boosting mitochondrial function in Alzheimer’s models, and examining the expanding role of GLP-1 receptor agonists in addressing the complex pathology of neurodegenerative diseases.
Together, these findings reflect a growing commitment to integrative, systems-level approaches that may one day transform how we support neural repair and resilience.
1. Combinatorial therapies for spinal cord injury repair
Combining cells, biomaterials, and molecules may hold the key to meaningful spinal cord repair. By targeting multiple layers of damage simultaneously, these integrative approaches are showing potential to enhance recovery and functional outcomes where single therapies fall short.
2. Aerobic exercise improves astrocyte mitochondrial quality and transfer to neurons in a mouse model of Alzheimer’s disease
Aerobic exercise improves the quality of mitochondria in astrocytes and enhances their transfer to neurons—helping reduce oxidative stress and cognitive decline in Alzheimer’s disease models.
3. Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
GLP-1 receptor agonists—commonly used in diabetes and obesity—are now showing real potential in slowing cognitive decline and improving motor function in neurodegenerative diseases like Alzheimer’s and Parkinson’s. While early trials are promising, long-term effectiveness, delivery methods, and patient selection remain key challenges for this emerging therapy.
If you’d like to stay informed of the latest publications and breakthroughs in neuron regeneration, join our email newsletter to the right (or below on mobile). We send out weekly updates with the latest papers and studies, as well as podcast episodes with the people driving Neuroregenerative breakthroughs.
